In contrast, treatment with CrPic reversed these changes, highlighting the fact that CrPic prevents diabetes-induced kidney fibrosis and glomerular sclerosis by inhibiting the TGF-β1/Smad2/3 pathway. Here, TGFB1 is linked to glomerulosclerosis.